Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Orthofix Medical Inc. - Common Stock (NQ:OFIX)

14.76 -0.40 (-2.67%)
Streaming Delayed Price Updated: 1:41 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orthofix Medical Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Why One Hedge Fund Just Put $246 Million Into This Life Sciences Supplier ↗
One fund has turned nearly a third of its portfolio into a bet that this beaten-down science supplier is due for a rebound. 
Via The Motley Fool
Topics Economy Regulatory Compliance Supply Chain
News headline image
Why One Fund Dumped Its Entire $15 Million Stake as This Defense Stock Posted $47 Billion in Backlog ↗
Why would a fund step away from a stock that’s quietly building one of the strongest backlogs in federal contracting? 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Fund Just Bet $64 Million on a Healthcare Stock Down 63% This Past Year ↗
This hedge fund just made a bold bet on a behavioral-health giant in the middle of a reset—here’s what they may be seeing. 
Via The Motley Fool
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 25, 2025 ↗
 
Via Benzinga
News headline image
Top 2 Health Care Stocks That May Crash In February ↗
 
Via Benzinga
News headline image
Orthofix Medical Inc (NASDAQ:OFIX) Surpasses Q3 2025 Profit Expectations Despite Muted Market Reaction ↗
Orthofix (OFIX) Q3 2025 earnings beat estimates with $0.20 EPS vs. $(0.41) forecast. Revenue of $205.6M also surpassed expectations, driven by strong spine and orthopedics growth. 
Via Chartmill
Topics Earnings
News headline image
Orthofix Reports Third Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Insights Ahead: Orthofix Medical's Quarterly Earnings ↗
 
Via Benzinga
News headline image
Orthofix to Participate in Upcoming Investor Conferences
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Report Third Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage ↗
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target. 
Via Benzinga
News headline image
Orthofix (OFIX) Q2 Revenue Rises 2% ↗
Via The Motley Fool
News headline image
Orthofix Reports Second Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Report Second Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Reports First Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Report First Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Appointment of Vickie Capps to Board of Directors
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Participate in the 37th Annual Roth Conference
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference
From Orthofix Medical Inc.
Via Business Wire
News headline image
Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
This Analyst Says Orthopedic-Focused Orthofix Medical Is Positioned For Growth ↗
Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.